Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Viewpoint
  • Published:

Do we need new indicators of dialysis adequacy based on middle-molecule removal?

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Lowrie EG et al. (1981) Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med 305: 1176–1181

    Article  CAS  Google Scholar 

  2. Gotch FA and Sargent JA (1985) A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 28: 526–534

    Article  CAS  Google Scholar 

  3. Vanbelleghem H et al. (2007) The Kidney Disease: improving Global Outcomes website: comparison of guidelines as a tool for harmonization. Kidney Int 71: 1054–1061

    Article  CAS  Google Scholar 

  4. Johnson WJ et al. (1972) Effects of urea loading in patients with far-advanced renal failure. Mayo Clin Proc 47: 21–29

    CAS  PubMed  Google Scholar 

  5. Eloot S et al. (2005) Kinetic behavior of urea is different from that of other water-soluble compounds: the case of the guanidino compounds. Kidney Int 67: 1566–1575

    Article  CAS  Google Scholar 

  6. Eloot S et al. (2007) Impact of hemodialysis duration on the removal of uremic retention solutes. Kidney Int [10.1038/sj.ki.5002750]

  7. Eknoyan G et al. (2002) Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347: 2010–2019

    Article  Google Scholar 

  8. Vanholder R et al. (2003) Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 63: 1934–1943

    Article  CAS  Google Scholar 

  9. Vanholder R et al. (2001) Uremic toxicity: present state of the art. Int J Artif Organs 24: 695–725

    Article  CAS  Google Scholar 

  10. Vanholder R et al. The middle molecule hypothesis thirty years after: lost and rediscovered in the universe of uremic toxicity? J Nephrol, in press

  11. Revillard JP et al. (1982) Beta 2-microglobulin and beta 2-microglobulin-binding proteins in inflammatory diseases. Eur J Rheumatol Inflamm 5: 398–405

    CAS  PubMed  Google Scholar 

  12. Cheung AK et al. (2006) Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol 17: 546–555

    Article  CAS  Google Scholar 

  13. Ward RA et al. (2000) A comparison of on-line hemodiafiltration and high-flux hemodialysis: a prospective clinical study. J Am Soc Nephrol 11: 2344–2350

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Raymond Vanholder.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vanholder, R., Eloot, S. & Van Biesen, W. Do we need new indicators of dialysis adequacy based on middle-molecule removal?. Nat Rev Nephrol 4, 174–175 (2008). https://doi.org/10.1038/ncpneph0750

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0750

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing